102 related articles for article (PubMed ID: 29758193)
1. Inhibition of pancreatic cancer Panc1 cell migration by omeprazole is dependent on aryl hydrocarbon receptor activation of JNK.
Jin UH; Karki K; Kim SB; Safe S
Biochem Biophys Res Commun; 2018 Jun; 501(3):751-757. PubMed ID: 29758193
[TBL] [Abstract][Full Text] [Related]
2. Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway.
Jin UH; Kim SB; Safe S
Chem Res Toxicol; 2015 May; 28(5):907-18. PubMed ID: 25826687
[TBL] [Abstract][Full Text] [Related]
3. The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis.
Jin UH; Lee SO; Pfent C; Safe S
BMC Cancer; 2014 Jul; 14():498. PubMed ID: 25011475
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole induces NAD(P)H quinone oxidoreductase 1 via aryl hydrocarbon receptor-independent mechanisms: Role of the transcription factor nuclear factor erythroid 2-related factor 2.
Zhang S; Patel A; Moorthy B; Shivanna B
Biochem Biophys Res Commun; 2015 Nov; 467(2):282-7. PubMed ID: 26441083
[TBL] [Abstract][Full Text] [Related]
5. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
[TBL] [Abstract][Full Text] [Related]
6. TCDD and omeprazole prime platelets through the aryl hydrocarbon receptor (AhR) non-genomic pathway.
Pombo M; Lamé MW; Walker NJ; Huynh DH; Tablin F
Toxicol Lett; 2015 May; 235(1):28-36. PubMed ID: 25797602
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of omeprazole and lansoprazole enantiomers on aryl hydrocarbon receptor in human hepatocytes and cell lines.
Novotna A; Srovnalova A; Svecarova M; Korhonova M; Bartonkova I; Dvorak Z
PLoS One; 2014; 9(6):e98711. PubMed ID: 24887303
[TBL] [Abstract][Full Text] [Related]
8. Identification of amino acid residues in the ligand-binding domain of the aryl hydrocarbon receptor causing the species-specific response to omeprazole: possible determinants for binding putative endogenous ligands.
Shiizaki K; Ohsako S; Kawanishi M; Yagi T
Mol Pharmacol; 2014 Feb; 85(2):279-89. PubMed ID: 24265133
[TBL] [Abstract][Full Text] [Related]
9. Dephosphorylation of Sp1 at Ser-59 by protein phosphatase 2A (PP2A) is required for induction of CYP1A1 transcription after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or omeprazole.
Shimoyama S; Kasai S; Kahn-Perlès B; Kikuchi H
Biochim Biophys Acta; 2014 Feb; 1839(2):107-15. PubMed ID: 24382322
[TBL] [Abstract][Full Text] [Related]
10. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression.
Hwang YP; Yun HJ; Choi JH; Kang KW; Jeong HG
Mol Nutr Food Res; 2010 Jul; 54(7):977-90. PubMed ID: 19943262
[TBL] [Abstract][Full Text] [Related]
11. Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor.
Narasimhan S; Stanford Zulick E; Novikov O; Parks AJ; Schlezinger JJ; Wang Z; Laroche F; Feng H; Mulas F; Monti S; Sherr DH
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29735912
[TBL] [Abstract][Full Text] [Related]
12. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells.
Veit C; Genze F; Menke A; Hoeffert S; Gress TM; Gierschik P; Giehl K
Cancer Res; 2004 Aug; 64(15):5291-300. PubMed ID: 15289335
[TBL] [Abstract][Full Text] [Related]
13. Role of CYP3A4 in the regulation of the aryl hydrocarbon receptor by omeprazole sulphide.
Gerbal-Chaloin S; Pichard-Garcia L; Fabre JM; Sa-Cunha A; Poellinger L; Maurel P; Daujat-Chavanieu M
Cell Signal; 2006 May; 18(5):740-50. PubMed ID: 16109480
[TBL] [Abstract][Full Text] [Related]
14. Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinases.
Backlund M; Ingelman-Sundberg M
Cell Signal; 2005 Jan; 17(1):39-48. PubMed ID: 15451023
[TBL] [Abstract][Full Text] [Related]
15. Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4.
Lee CC; Yang WH; Li CH; Cheng YW; Tsai CH; Kang JJ
Cancer Lett; 2016 Jul; 376(2):211-7. PubMed ID: 27060206
[TBL] [Abstract][Full Text] [Related]
16. Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells.
Zhang WW; Zhan SH; Geng CX; Sun X; Erkan M; Kleeff J; Xie XJ
Mol Med Rep; 2016 Oct; 14(4):3627-33. PubMed ID: 27573419
[TBL] [Abstract][Full Text] [Related]
17. Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism.
Diry M; Tomkiewicz C; Koehle C; Coumoul X; Bock KW; Barouki R; Transy C
Oncogene; 2006 Sep; 25(40):5570-4. PubMed ID: 16619036
[TBL] [Abstract][Full Text] [Related]
18. Activation of mitogen-activated protein kinases (MAPKs) by aromatic hydrocarbons: role in the regulation of aryl hydrocarbon receptor (AHR) function.
Tan Z; Chang X; Puga A; Xia Y
Biochem Pharmacol; 2002 Sep; 64(5-6):771-80. PubMed ID: 12213569
[TBL] [Abstract][Full Text] [Related]
19. Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke.
Ishida M; Mikami S; Shinojima T; Kosaka T; Mizuno R; Kikuchi E; Miyajima A; Okada Y; Oya M
Int J Cancer; 2015 Jul; 137(2):299-310. PubMed ID: 25523818
[TBL] [Abstract][Full Text] [Related]
20. Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer.
Ishida M; Mikami S; Kikuchi E; Kosaka T; Miyajima A; Nakagawa K; Mukai M; Okada Y; Oya M
Carcinogenesis; 2010 Feb; 31(2):287-95. PubMed ID: 19755661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
